Moffitt Cancer Center
Tampa, FL USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Moffitt Cancer Center Researchers Make Important Steps toward Developing a Blood Test to Catch Pancreatic Cancer Early

Pancreatic cancer is the fourth most common cause of cancer-related death in the United States and has a 5-year survival rate of only 6 percent, which is the lowest rate of all types of cancer according to the American Cancer Society.  This low...
28-Aug-2015 10:00 AM EDT Add to Favorites

Study Finds Young Black Women Have a Higher Frequency of BRCA Mutations Than Previously Reported

Moffitt Cancer Center researchers recently conducted the largest U.S. based study of BRCA mutation frequency in young black women diagnosed with breast cancer at or below age 50 and discovered they have a much higher BRCA mutation frequency than...
25-Aug-2015 9:00 AM EDT Add to Favorites

Moffitt Cancer Center’s Dr. James J. Mulé Named Master of Immunology

James J. Mulé, Ph.D., associate center director for Translational Science at Moffitt Cancer Center, has been named a Master of Immunology by the American Association for Cancer Research (AACR) publication Cancer Immunology Research.
5-Aug-2015 11:05 AM EDT Add to Favorites

Moffitt Cancer Center Teams Up with MD Anderson to Discover, Test Novel Agents to Prevent Cancer

Moffitt Cancer Center has joined MD Anderson’s National Cancer Institute (NCI) Phase 0/I/II Cancer Prevention Clinical Chemoprevention Trials Consortia. Sponsored by the NCI’s Division of Cancer Prevention, the consortia conducts early clinical...
30-Jul-2015 10:00 AM EDT Add to Favorites

Cancer Healthcare Disparities Exist in the LGBTQ Community, Say Moffitt Cancer Center Researchers

The Lesbian, Gay, Bisexual, Transgender/Transsexual, Queer/Questioning (LGBTQ) community is a growing and medically-underserved minority population in the United States, with 3 to 12 percent of the population estimated to identify as LGBTQ. Moffitt...
28-Jul-2015 10:30 AM EDT Add to Favorites

Race and Institutional Factors Play an Important Role in Pharmacogenomic Trial Participation, Say Moffitt Cancer Center Researchers

Moffitt Cancer Center researchers have published a study in the Journal of the National Cancer Institute that analyzed the participation rate of patients in pharmacogenomic trials.
28-Jul-2015 10:00 AM EDT Add to Favorites

Moffitt Cancer Center Researchers Develop First Genetic Test to Predict Tumor Sensitivity to Radiation Therapy

Moffitt Cancer Center researchers have contributed to these advances by developing the first test that analyzes the sensitivity of tumors to radiation therapy. They discovered that colon cancer metastases have varying sensitivity to radiation...
23-Jul-2015 9:30 AM EDT Add to Favorites

Moffitt Cancer Center Receives $3.6 Million Grant to Study E-Cigarettes

Moffitt Cancer Center received a $3.6 million grant from the National Institutes of Health to study the use of electronic cigarettes, or e-cigarettes, over the next five years.
30-Jun-2015 9:00 AM EDT Add to Favorites

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos